fig2

Assessment of response to liver directed radiation-based therapies: Current guidelines, challenges, and future directions

Figure 2. 76-year-old male, hepatitis C cirrhosis, MR images. On pretreatment images, a 4.3 cm arterial phase hyperenhancing (asterisk) observation with portal venous phase washout (arrows) in the right lobe is consistent with HCC (LR-5). Follow-up images 6 months after Y-90 radioembolization shows a larger appearance of the mass due to treatment changes. The lack of arterial phase hyperenhancement (asterisk) and irregular progressive enhancement on portal venous phase (black arrows) are consistent with post-treatment changes (LR-TR Nonviable).

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/